Pharmaceutical Name
Coccidosis vaccine -- Eimeria acervulina, E. mivatti, E. maxima, E. tenella -- Live Oocysts, Chicken Isolates

Description
Live coccidiosis vaccine for broilers. 

Composition
Coccivac®-B contains live oocysts of:

• Eimeria acervulina
• Eimeria mivatti
• Eimeria maxima
• Eimeria tenella

Product Uniqueness

• Drug-free, residue-free and resistance-free control of Coccidiosis
• Highly sensitive oocysts, isolated previous to the development and use of the anticoccidial drugs, restore drug sensitivity
• Replaces field oocysts if vacine oocysts, reducing the pathogenicity and restoring drug sensitivity
• Used by the Spraycox® II or Spraycox® Jr., high uniformity and excellent protection

Therapeutic Superiority

• Protects against all Eimeria spp. important to broilers
• Birds remain protected for entire broiler cycle after a single administration
• Reduces risk of late outbreaks
• Eliminates undesirable side effects of coccidiostats
• Eliminates risk of toxicity in non-target species
• No need for complicated drug medication schemes

Features and Benefits

• Repopulate the field with sensitive oocysts
• Ideal for improving long-term control of Coccidiosis and performance
• Proven economical feasibility
• Eliminates residue concerns for consumers
• Support of the Schering-Plough Poultry Team in managing Intestinal Health and improving performance

Indications
For vaccination of healthy chickens at one day of age or older as an aid in preventing performance losses or mortality due to coccidiosis.

Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Coccivac®-B is a registered trademark of Schering-Plough Animal Health Corporation.